Keudell Abb Vie Inc. Transaction History

Keudell

$341 Million
Q2 2024

A detailed history of Keudell transactions in Abb Vie Inc. stock. As of the latest transaction made, Keudell holds 22,302 shares of ABBV stock, worth $4.23 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

22,302

Previous 22,568 1.18%

Holding current value

$4.23 Million

Previous $4.11 Million 6.91%

% of portfolio

1.12%

Previous 1.25%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$154.79 - $180.76 $41,174 - $48,082	-266 Reduced 1.18%	22,302 $3.83 Million
Q1 2024 May 07, 2024	SELL	$159.82 - $182.1 $219,912 - $250,569	-1,376 Reduced 5.75%	22,568 $4.11 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $72,928 - $82,134	-530 Reduced 2.17%	23,944 $3.71 Million
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $70,001 - $81,036	-524 Reduced 2.1%	24,474 $3.65 Million
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $117,006 - $145,606	-883 Reduced 3.41%	24,998 $3.37 Million
Q1 2023 Apr 18, 2023	SELL	$144.61 - $166.54 $54,373 - $62,619	-376 Reduced 1.43%	25,881 $4.12 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $53,249 - $63,859	-385 Reduced 1.45%	26,257 $0
Q3 2022 Oct 12, 2022	SELL	$134.21 - $153.93 $48,584 - $55,722	-362 Reduced 1.34%	26,642 $3.58 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $297,947 - $378,788	-2,165 Reduced 7.42%	27,004 $4.14 Million
Q1 2022 Apr 18, 2022	SELL	$131.98 - $163.75 $103,472 - $128,380	-784 Reduced 2.62%	29,169 $4.73 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $82,076 - $103,850	-764 Reduced 2.49%	29,953 $4.06 Million
Q3 2021 Oct 20, 2021	BUY	$106.4 - $120.78 $156,301 - $177,425	1,469 Added 5.02%	30,717 $3.31 Million
Q2 2021 Jul 13, 2021	BUY	$105.21 - $117.21 $35,560 - $39,616	338 Added 1.17%	29,248 $3.3 Million
Q1 2021 Apr 13, 2021	BUY	$102.3 - $112.62 $194,881 - $214,541	1,905 Added 7.05%	28,910 $3.13 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $32,115 - $43,359	-399 Reduced 1.46%	27,005 $2.89 Million
Q3 2020 Oct 20, 2020	SELL	$85.91 - $100.83 $45,618 - $53,540	-531 Reduced 1.9%	27,404 $2.4 Million
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $83,935 - $112,317	1,144 Added 4.27%	27,935 $2.74 Million
Q1 2020 Apr 20, 2020	BUY	$64.5 - $97.79 $82,108 - $124,486	1,273 Added 4.99%	26,791 $2.04 Million
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $29,933 - $37,453	415 Added 1.65%	25,518 $2.26 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $86,660 - $104,190	1,376 Added 5.8%	25,103 $1.9 Million
Q2 2019 Aug 23, 2019	BUY	$65.7 - $83.98 $1.56 Million - $1.99 Million	23,727 New	23,727 $1.53 Million
Q2 2019 Aug 21, 2019	SELL	$65.7 - $83.98 $1.3 Million - $1.67 Million	-19,854 Closed	0 $0
Q1 2019 Aug 21, 2019	BUY	$77.14 - $90.79 $1.53 Million - $1.8 Million	19,854 New	19,854 $1.6 Million

Others Institutions Holding ABBV

# of Institutions

3,757

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.84M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $335B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.

Account